ReviewPlant biotechnology journal2026
Engineering Conditional Transgene Expression in Nicotiana benthamiana.
Review in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Duckweeds: from fundamental biology to a sustainable plant chassis for biotechnology.Advanced biotechnology · 2026Review
- Advances in promoter engineering strategies for enhanced recombinant protein expression in plants.Frontiers in plant science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nicotiana benthamiana has emerged as a premier plant biofactory for recombinant protein and metabolite production due to its high metabolic versatility, ease of cultivation and permissiveness to transient expression vectors. However, challenges such as transgene silencing, low yields and metabolic toxicity limit its scalability. Synthetic gene circuits offer transformative solutions by enabling precise transgene expression control, dynamic signal processing and metabolic pathway optimization. Recent advancements include novel sensor systems responsive to chemical and electromagnetic signals, synthetic promoters integrated with programmable transcription factors and virus-derived replicons for transcriptional signal amplification. Recombinase-based processors further enhance conditional gene expression and cellular memory capabilities. Innovative platforms like plant cell packs and self-sustained bioluminescence systems facilitate rapid prototyping of gene circuits, enabling high-throughput screening and optimization. Future strategies focus on stable genomic integration, positional effect mitigation and accelerated transgenic line generation using morphogenic regulators and CRISPR systems. By addressing these challenges, synthetic biology can unlock the full potential of N. benthamiana as a scalable and sustainable biofactory for molecular farming, biosensing and advanced bioproduction applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.